Time lapse analysis of tumor response in patients with soft tissue sarcoma treated with trabectedin: A pooled analysis of two phase II clinical trials-Reference-Cited by-同舟云学术

Time lapse analysis of tumor response in patients with soft tissue sarcoma treated with trabectedin: A pooled analysis of two phase II clinical trials

Published:2020-03-27 Issue:11 Volume:9 Page:3656-3667
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Endo Makoto¹,Takahashi Shunji²,Araki Nobuhito³,Sugiura Hideshi⁴,Ueda Takafumi⁵,Yonemoto Tsukasa⁶,Takahashi Mitsuru⁷,Morioka Hideo⁸,Hiraga Hiroaki⁹,Hiruma Toru¹⁰,Kunisada Toshiyuki¹¹,Matsumine Akihiko¹²,Goda Kazato¹³,Kawai Akira¹⁴^ORCID

Affiliation:

1. Department of Orthopaedic Surgery Kyushu University Fukuoka Japan

2. Department of Medical Oncology Cancer Institute Hospital of Japanese Foundation for Cancer Research Tokyo Japan

3. Department of Orthopaedic Surgery Osaka International Cancer Institute Osaka Japan

4. Department of Physical Therapy Nagoya University Nagoya Japan

5. Department of Orthopaedic Surgery National Hospital Organization Osaka National Hospital Osaka Japan

6. Division of Orthopaedic Surgery Chiba Cancer Center Chiba Japan

7. Division of Orthopaedic Surgery Shizuoka Cancer Center Hospital Nagaizumi Japan

8. Department of Orthopaedic Surgery National Hospital Organization Tokyo Medical Center Tokyo Japan

9. Department of Orthopaedic Surgery Hokkaido Cancer Center Sapporo Japan

10. Department of Musculoskeletal Tumor Surgery Kanagawa Cancer Center Yokohama Japan

11. Department of Orthopaedic Surgery Okayama University Hospital Okayama Japan

12. Department of Orthopaedic Surgery Fukui University Fukui Japan

13. Department of Medical affairs Taiho Pharmaceutical Co. Ltd Tokyo Japan

14. Department of Musculoskeletal Oncology National Cancer Center Hospital Tokyo Japan

Funder

Taiho Pharmaceutical Co., Ltd.

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2991

Reference14 articles.

1. Pseudoprogression and Immune-Related Response in Solid Tumors

2. Pharmacokinetics and pharmacodynamics of the novel marine‐derived anticancer agent ecteinascidin 743 in a phase I dose‐finding study;Kesteren C;Clin Cancer Res,2000

3. Overall survival and histology‐specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma

4. Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study

5. Retrospective inter- and intra-patient evaluation of trabectedin after best supportive care for patients with advanced translocation-related sarcoma after failure of standard chemotherapy

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG);Journal of Clinical Oncology;2024-03-10

2. Effectiveness and Safety of Trabectedin and Radiotherapy for Patients With Myxoid Liposarcoma;JAMA Oncology;2023-05-01

3. Clinical characteristics of sarcoma cases in which long-term disease control was achieved with trabectedin treatment: A retrospective study;PLOS ONE;2023-03-01

4. Consecutive Inhibition of Telomerase and Alternative Lengthening Pathway Promotes Hodgkin’s Lymphoma Cell Death;Biomedicines;2022-09-16

5. Trabectedin as second-line treatment in advanced soft tissue sarcoma: quality of life and safety outcomes;Future Oncology;2022-09